Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02403401 · ClinicalTrials.gov registry record · Phase 3
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,471
- Enrollment target
NCT02403401: Completed Phase 3 study, sponsored by Bayer.
NCT02403401 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 1,471 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02403401, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,471 participants
- Enrollment target
Study Summary
Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.
Primary Outcome
Pearl Index = Number of pregnancies per 100 woman-years of exposure
Interventions
- DRUG Levonorgestrel (BAY98-7196)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,471 participants |
| Start Date | 2015-05-15 |
| Est. Completion | 2016-07-07 |
| Phase | Phase 3 |
What the finished NCT02403401 record still lists
NCT02403401 is an interventional study that assigns participants to a tested intervention. Its 1,471 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% higher).
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel (BAY98-7196) is the first listed.
NCT02403401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02403401 about?
NCT02403401 is a clinical study titled "Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women". Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.
What is the current status of trial NCT02403401?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,471 participants. The study started on 2015-05-15. Estimated completion is 2016-07-07.
What interventions are being tested in trial NCT02403401?
The interventions under investigation include: Levonorgestrel (BAY98-7196) (DRUG).
Who is sponsoring clinical trial NCT02403401?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02403401's enrollment target sits among peer trials
1,471 163rd of 2000 higher than 1,838 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI